.Attributes Medicine, Posted online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antitoxin-- medicine conjugate (ADC) tisotumab vedotin caused strengthened progression-free and also total survival, triggering FDA commendation and a new procedure choice for clients.